
In a mortgage fund, the valuation is the risk control. LVR covenants, drawdown tests, security cover — all of it resolves to a number produced by an external professional. Which makes the question of who produces that number, and how they are chosen, one of the more revealing things an investor can ask a manager about.
The answer, in a well-run book, is a panel. Here is why.
If a lender unilaterally dictates the single valuer a borrower must use, that looks — and can actually be — biased toward whatever figure suits the lender. The valuer knows where their work comes from.
A panel of several pre-vetted firms, with the borrower choosing which panel member to instruct rather than the manager assigning one, removes the appearance of steering without giving up control over quality. The manager still decides who is allowed on the panel; it just does not decide which of them values a given asset.
There is a commercial dimension too. A borrower who does not trust a lender’s sole valuer takes their deal elsewhere. Choice within a vetted panel is a deal-flow feature as much as a governance one.
Relying on one firm, or one individual within a firm, means a single adverse event removes your entire valuation capability at once: a reputational collapse, a loss of licence, a key-person departure, an insurer withdrawing cover.
This is ordinary single-supplier concentration risk, and it deserves the same treatment as any other. The difference is that a fund cannot simply pause while it finds a replacement — every live facility with a revaluation obligation, every pending drawdown, and every new settlement depends on that capability being continuously available.
The stronger version of the control is a hard cap: a stated limit on how much of the total loan book any single valuer or QS may have assessed. A limit in the region of 30–35% is a reasonable reference point.
What makes this useful is that it is enforceable against a borrower’s preference. When a developer insists on a particular valuer they have used before, a manager with a documented cap can decline — citing the fund’s own governing documents rather than a matter of opinion. That is a materially stronger position than a case-by-case judgement call, and it is the kind of provision worth confirming exists in writing.
A valuer or QS judged acceptable today — on experience, reputation, and any legal action on foot against them — is not guaranteed to still meet that bar in twelve or twenty-four months.
Panel governance should therefore include a re-review cadence, not just an admission process. Initial vetting is the easy part; the discipline is in reassessing firms that have been on the panel long enough for everyone to have stopped thinking about them.
This is the point most often misunderstood, and it matters more than the rest.
A deal still has to clear investment-committee scrutiny regardless of who wrote the reports. Panel membership only determines who is allowed to do the work — it does not pre-approve the contents of what they produce.
If a valuation or QS report from an on-panel firm is materially wrong, internally contradictory, or inconsistent with the documents it purports to rely on, the correct response is to reject that report and instruct a different panel member. Not to wave it through because the firm is approved. A manager who treats panel membership as a substitute for reading the report has converted a control into a rubber stamp.
A fund usually has no contractual sanction against a valuer for a poor report. What it has is future work — and that turns out to be enough.
Repeated substandard reports are how a firm loses future panel work, then its standing with its professional body, then its business generally. That is the deterrent that keeps panel firms honest without contract-level penalties, and it only functions if managers actually reject bad reports rather than absorbing them.
The related point: a valuer with a long referral relationship may quote a reduced fee or faster turnaround as a commercial accommodation. That does not change their obligations. Their professional indemnity cover and their licence remain on the line regardless of the commercial relationship, and a valuer who lets a good relationship compromise the figure carries exactly the same exposure as one who does it for any other reason.
Mainstream lenders mostly do not run this problem manually. Standard residential and investment valuations are allocated through a shared industry platform: the originator enters the address, the lender and the deal metrics, and the platform’s own rules determine both the report type required and which panel firm receives the job, at standard pricing.
That allocation is deliberately randomised and rules-driven precisely to remove originator and lender influence — the institutional equivalent of the panel-plus-borrower-choice model above.
Access to those platforms is realistically limited to established, larger lenders. A newer or smaller private lender generally cannot subscribe for its own book, and engages valuers and QS firms directly with the chosen panel firm instead.
Which is exactly why panel composition, the concentration limit, and the re-review cadence matter more for a private credit manager than for an institution that has a platform doing the allocation for it. If you are assessing a private credit manager, that is the gap to probe.
General information only, prepared for wholesale investors. It is not financial product advice, does not take account of your objectives, financial situation or needs, and is not an offer of, or invitation to acquire, any financial product.